ABcann Global Enters Its Growth Phase (with Exclusive Interview)
September 20th, 2017
Exclusive, News, Top News
Canada’s cannabis industry is expected to reach C$22.6 billion over the coming years, according to Deloitte, as recreational legalization goes into effect next year. Despite about 60 licensed producers approved by Health Canada, the market is expected to experience a shortfall in production that could lead to an opportunity for investors. Licensed producers like ABcann Global Corporation (TSX-V: ABCN) (OTCQB: ABCCF) could see significant upside.
CFN Media recently interviewed former CEO Aaron Keay to discuss the company’s transition and its long-term goals in the space:
In this article, we will look at the company’s recent leadership transition, new product launches, and other reasons that investors may want to consider the stock.
A Company in Transition
Aaron Keay has been instrumental in guiding ABcann Global through the process of raising capital and becoming a public company. With over a decade of experience working in the capital markets, Mr. Keay was the perfect person to spearhead these efforts and guide the company on its way to becoming a premier licensed producer. The appointment of new CEO Barry Fishman marks an important turning point as Keay looks to focus on operations moving forward.
Barry Fishman has nearly 20 years of experience in executives role at pharmaceutical companies where he was instrumental in growing them. In his most recent position, he served as CEO of the international specialty pharmaceutical company Merus Labs (TSE: MSL) (NASDAQ: MSLI), where he grew revenue and EBITDA at a compound annual growth rate of more than 50% before Norgine BV acquired the company for $342 million in July 2017.
In addition to Merus Labs, Fishman has previously served as CEO of both Teva Canada and Taro Canada and was Chair of the Canadian Generic Manufacturers Association. He also served in various cross-functional leadership roles at Eli Lilly & Co. (NYSE: LLY), including Vice President of Marketing. And finally, he has served on the Board of Directors for several cannabis companies, which provides him with extensive insights into the sector.
Improving Operations & Financials
ABcann Global has made tremendous progress since the beginning of the year. In preparation for its growth phase, the company completed multiple financings including a subscription receipt offering for $11.8 million and a private placement for $15 million in proceeds. This capital is being deployed to expand its fully-operational Vanluven facility and initiate construction of its 150,000 square foot Kimmett facility in recent months.
The company also announced a strategic partnership with Cannabis Wheaton Income Corp. (TSX-V: CBW) that includes a $30 million investment and the opportunity to finance a 50,000 square foot expansion facility in a 50/50 joint venture. The company also continues to see strong demand for its premium, organically-grown, pesticide-free cannabis products in the domestic market as it looks to expand into international markets down the road.
Finally, ABcann has also benefited from its inclusion in the Horizons Medical Marijuana Life Sciences ETF, which is the first ETF that provides investors with direct exposure to a basket of North American publicly-listed companies that meet minimum asset and liquidity thresholds. The inclusion in the ETF improves the company’s credibility among institutional investors and could help improve liquidity for investors over the long run.
ABcann Global Corporation (TSX-V: ABCN) (OTCQB: ABCCF) represents a compelling investment opportunity in Canada’s burgeoning cannabis industry. With a market capitalization of just C$90 million, the company trades at a fraction of the valuation of many of its competitors despite having organically-grown, pesticide-free product that can be grown at a much higher yield than conventional cannabis technologies used by competitors.
Investors may want to take a closer look at the stock as it transitions from the development stage into the commercialization stage under new leadership. With a well-capitalized balance sheet, ABcann has fully-financed expansion plans that could make it a leader in the space with a premium product that’s in demand among consumers.
For more information, visit the company’s website at www.abcannglobal.com.
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.